Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients. (Q52916930)
Jump to navigation
Jump to search
scientific article published in April 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients. |
scientific article published in April 1999 |
Statements
Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients. (English)
Cosson VF
Fuseau E
1 April 1999
27
2
149-171
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference